Windlas Biotech reported strong financial results for H1 FY25, achieving a revenue of Rs. 362.2 crores, a 21.7% increase YoY, with EBITDA of Rs. 43.9 crores, reflecting a 22.6% growth YoY.
AI Assistant
Windlas Biotech Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.